CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus 🔓 Açık Erişim YÖKSİS DOI Eşleşti SJR Q3

Evaluation of medication and herbal product use among pregnant women

Acta Pharmaceutica Sciencia · Ocak 2021

YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Evaluation of Medication and Herbal Product Use Among Pregnant Women
Acta Pharmaceutica Sciencia · 2021 Scopus
Dr. Öğr. Üyesi CENGİZHAN CEYLAN →
YÖKSİS ISSN Eşleşmesi

Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.

YÖKSİS Kayıtları — ISSN Eşleşmesi
Hepatoprotective effects of coriandrum sativum essential oil against acute hepatotoxicity induced by carbon tetrachloride on rats
2016 ISSN: 1307-2080 International Pharmaceutical Abstracts
Prof. Dr. ENDER ERDOĞAN →
Evaluation of Medication and Herbal Product Use Among Pregnant Women
2021 ISSN: 1307-2080 Scopus
Dr. Öğr. Üyesi CENGİZHAN CEYLAN →

Makale Bilgileri

Dergi Acta Pharmaceutica Sciencia
ISSN13072080
Yayın TarihiOcak 2021
Cilt / Sayfa59 · 575-588
DOI10.23893/1307-2080.APS.05936
Scopus ID2-s2.0-85117902580
Erişim🔓 Açık Erişim
Özet The use of medications and herbal products among women increases after pregnancy. The purpose of the study is to evaluate the frequency of medication used and analyzed them based on the FDA pregnancy risk categories. This cross-sectional study was conducted on 300 adult volunteers attending antenatal care in a university-affiliated hospital. Medications were classified according to the FDA pregnancy risk classification. In 97,7% of women, the use of at least one medication during pregnancy. The median count for Category A medications was 2. Category C and B medications were reported by 100 (33,3%) and 53 women (17,7%). There was a significant difference between the education level and the use of herbal products (p=0.043). Pharmacists should take a greater role in educating pregnant women and women of childbearing age about the possible consequences of medications on the development of the fetus and guide healthcare practitioners in choosing the most appropriate medications.

Yazarlar (5)

1
Rashida Muhammad Umar
ORCID: 0000-0001-8902-7274
2
Rabia Beşiroğlu
ORCID: 0000-0003-3188-4278
3
Ayşe Kevser Şahin
ORCID: 0000-0003-0223-2959
4
Emine Karataş Koçberber
ORCID: 0000-0003-2803-0992
5
Cengizhan Ceylan
ORCID: 0000-0003-4164-9212

Anahtar Kelimeler

FDA risk category Herbal product use Medication use Pregnancy

Kurumlar

İstanbul Medipol Üniversitesi
Istanbul Turkey
Marmara Üniversitesi
Istanbul Turkey
Selçuk Üniversitesi
Selçuklu Turkey
Scimago Dergi (ISSN Eşleşmesi)
Acta Pharmaceutica Sciencia
Q3 OA
SJR Skoru0,179
H-Index23
YayıncıIstanbul Medipol University
ÜlkeTurkey
Pharmaceutical Science (Q3)
Dergi sayfasına git

Metrikler

1
Atıf
5
Yazar
4
Anahtar Kelime

Sistemimizdeki Yazarlar

CC
CENGİZHAN CEYLAN
Dr. Öğr. Üyesi

Hızlı Erişim

DOI ile aç Scopus'ta aç Makaleler listesi